FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

Vertex recieved approval for Journav, the first new class of pain medicine approved in more than 20 years. With more than 80 million Americas suffering from moderate-to-severe acute pain each year, this drug could be the first step in addressing the opioid crisis.

https://ift.tt/6oirSOR Submitted February 28, 2025 at 03:26AM by PassivePrincess292 https://ift.tt/UdasXMB